Salesforce
CRM
Qualcomm
QCOM
Broadcom
AVGO
4
Oracle
ORCL
5
Netflix
NFLX
US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 34.000
- +0.770+2.32%
Trading Apr 24 10:26 ET
25.08BMarket Cap-109.68P/E (TTM)
34.530High32.480Low1.77MVolume33.000Open33.230Pre Close59.33MTurnover1.54%Turnover RatioLossP/E (Static)737.68MShares34.53052wk High64.52P/B3.92BFloat Cap2.10052wk Low--Dividend TTM115.17MShs Float34.530Historical High--Div YieldTTM6.17%Amplitude0.660Historical Low33.469Avg Price1Lot Size
Summit Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -85.13%-142.11M | -150.13%-48.67M | -103.38%-30.3M | -12.74%-33M | -129.49%-30.13M | -84.60%-76.76M | -474.86%-19.46M | -74.13%-14.9M | -52.33%-29.27M | 30.89%-13.13M |
| Net income from continuing operations | 64.01%-221.32M | -67.37%-61.2M | -164.50%-56.25M | -310.31%-60.39M | 91.98%-43.47M | -680.54%-614.93M | -90.17%-36.57M | 0.55%-21.27M | 12.25%-14.72M | -2,434.82%-542.38M |
| Operating gains losses | 117.09%229K | 61.14%-171K | 1.98%515K | 75.97%-124K | 101.01%9K | -151.22%-1.34M | 73.41%-440K | -73.49%505K | -138.83%-516K | -185.73%-889K |
| Depreciation and amortization | -55.05%89K | -26.67%22K | -37.50%20K | -56.52%20K | -70.00%27K | -84.32%198K | 104.58%30K | -95.51%32K | -92.22%46K | -85.37%90K |
| Other non cash items | -97.15%15.01M | --0 | 102.98%7K | ---- | ---- | 17,252.47%527.17M | -81.65%401K | -167.05%-235K | -96.77%24K | 266,050.51%526.98M |
| Change In working capital | 3,099.81%15.48M | -108.00%-686K | 114.48%8.96M | 122.96%3M | 2,393.99%4.2M | -105.23%-516K | -36.12%8.57M | -44.30%4.18M | -72.04%-13.08M | 94.70%-183K |
| -Change in receivables | -88.18%535K | -14.04%-203K | -92.47%260K | -390.57%-154K | -47.33%632K | -51.90%4.53M | -101.66%-178K | 15,790.91%3.45M | 196.36%53K | 199.09%1.2M |
| -Change in prepaid assets | -764.88%-7.91M | -421.10%-8.48M | -117.90%-181K | 172.41%3.55M | -943.50%-2.79M | -117.90%-914K | 2,513.86%2.64M | -73.22%1.01M | -237.42%-4.9M | -87.66%331K |
| -Change in payables and accrued expense | 5,959.89%20.45M | 14.68%7.56M | 323.30%8.97M | 125.74%1.77M | 198.00%2.16M | -115.45%-349K | 301.28%6.59M | -61.46%2.12M | -108.58%-6.86M | -37.84%-2.2M |
| -Change in other current assets | 172.20%2.47M | 948.84%365K | 93.85%-151K | 80.78%-275K | 398.23%2.53M | -1,691.16%-3.42M | 87.46%-43K | -224.75%-2.46M | -37.60%-1.43M | 237.30%508K |
| -Change in other current liabilities | --95K | 143.10%25K | -58.62%24K | ---1.72M | --1.76M | --0 | -106.51%-58K | 119.53%58K | --0 | --0 |
| -Change in other working capital | 53.48%-167K | 112.70%48K | 628.57%37K | -433.33%-160K | -318.18%-92K | 94.96%-359K | -188.32%-378K | 99.80%-7K | 103.26%48K | 99.17%-22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -85.13%-142.11M | -150.13%-48.67M | -103.38%-30.3M | -12.74%-33M | -129.49%-30.13M | -84.60%-76.76M | -474.86%-19.46M | -74.13%-14.9M | -52.33%-29.27M | 30.89%-13.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 65.06%-205.34M | 37.83%83.48M | -3,015.75%-108.62M | -96,756.52%-200.08M | 103.08%19.87M | -94,094.55%-587.77M | 605,580.00%60.57M | -17,530.00%-3.49M | 170.65%207K | -178,587.81%-645.06M |
| Net PPE purchase and sale | -241.84%-139K | -600.00%-14K | -9.43%-58K | -130.58%-63K | 92.45%-4K | 115.71%98K | -120.00%-2K | -365.00%-53K | 170.31%206K | 85.32%-53K |
| Net investment purchase and sale | -68.53%-190.2M | 37.85%83.5M | -2,625.02%-93.55M | -20,001,700.00%-200.02M | 111.69%19.88M | ---112.86M | --60.57M | ---3.43M | --1K | ---170M |
| Net other investing changes | 96.84%-15.01M | --0 | ---- | ---- | ---- | ---475.02M | --0 | --0 | --0 | ---475.02M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 65.06%-205.34M | 37.83%83.48M | -3,015.75%-108.62M | -96,756.52%-200.08M | 103.08%19.87M | -94,094.55%-587.77M | 605,580.00%60.57M | -17,530.00%-3.49M | 170.65%207K | -178,587.81%-645.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 340.66%381.23M | -477.67%-23.61M | 89,044.98%204.14M | 250,365.00%200.21M | -99.39%485K | -86.05%86.51M | -98.80%6.25M | -99.69%229K | -80K | 218.07%80.11M |
| Net issuance payments of debt | -305.09%-100M | ---24.5M | ---75.5M | --0 | --0 | -104.75%-24.69M | --0 | --0 | --0 | -198.74%-24.69M |
| Net common stock issuance | 335.69%477.89M | -101.87%-105K | 45,010.82%278M | --200M | --0 | 9.69%109.69M | --5.62M | -100.62%-619K | --0 | --104.69M |
| Proceeds from stock option exercised by employees | 56.38%3.33M | -20.69%993K | 617.90%1.64M | --212K | -25.50%485K | 434.34%2.13M | 1,103.85%1.25M | 112.04%229K | --0 | 248.13%651K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -299.35%-619K | ---- | ---- | ---80K | ---539K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 340.66%381.23M | -477.67%-23.61M | 89,044.98%204.14M | 250,365.00%200.21M | -99.39%485K | -86.05%86.51M | -98.80%6.25M | -99.69%229K | ---80K | 218.07%80.11M |
| Net cash flow | ||||||||||
| Beginning cash position | -88.99%71.43M | 295.50%94.1M | -31.73%28.75M | -13.19%61.61M | -88.99%71.43M | 803.47%648.61M | -80.49%23.79M | -26.54%42.12M | -8.37%70.97M | 803.47%648.61M |
| Current changes in cash | 105.84%33.78M | -76.36%11.2M | 459.31%65.23M | -12.77%-32.87M | 98.31%-9.78M | -200.00%-578.02M | -90.98%47.36M | -127.31%-18.15M | -49.39%-29.15M | -10,024.15%-578.08M |
| Effect of exchange rate changes | -102.15%-18K | -139.71%-108K | 167.06%114K | -95.90%12K | -108.11%-36K | 168.66%839K | -80.22%272K | 90.69%-170K | 148.43%293K | 367.47%444K |
| End cash Position | 47.27%105.19M | 47.27%105.19M | 295.50%94.1M | -31.73%28.75M | -13.19%61.61M | -88.99%71.43M | -88.99%71.43M | -80.49%23.79M | -26.54%42.12M | -8.37%70.97M |
| Free cash flow | -85.00%-142.25M | -150.18%-48.69M | -103.04%-30.36M | -12.88%-33.07M | -128.60%-30.14M | -82.17%-76.89M | -474.18%-19.46M | -75.16%-14.95M | -50.14%-29.29M | 31.91%-13.18M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀